Not just the coronavirus
Medical startups of 2020
Novel Mamchits, Invest-Foresight
There has been a lot of talk recently about the development of a vaccine against coronavirus. But medicine has other problems. This year, many startups have entered the market that are not related to the coronavirus, but this does not lose their relevance.
ABLE Human Motion
ABLE is a Spanish (Barcelona, Catalonia) startup that is the world's first manufacturer of robotic exoskeletons, whose goal is to improve the quality of life of people with disabilities. The lower body exoskeleton is the first product for people with lower limb paralysis. ABLE is uniquely lightweight and easy to use, which provides affordable mobility for people in wheelchairs who can start walking with this design. The ABLE project appeared in 2015 and was quickly evaluated by doctors. The startup hopes to complete clinical trials by the end of 2020 and begin pre-sale preparation in 2021. The award-winning startup started by studying the physiology of human gait to create a product that allows wheelchair users to get up, walk and sit down without . help. The exoskeleton weighs 8 kg
Abili Tech Medical
A startup from the USA, Minnesota, whose goal is to restore the working capacity of people with neuromuscular diseases of the upper extremities or their injuries. The startup creates a range of functional assistive devices to provide support in the types of daily activities that allow people with disabilities to achieve social, physical and economic activity. By the end of this year, the Assist device, a wearable mechanism that provides supported arm movement for patients with limited strength or range of motion, will be officially launched. Other products in active development include the Abili GRIP, an auxiliary device for patients with limited hand function. At the end of November 2019, Abili Tech announced that they had successfully raised $7.5 million in a fundraising round.
A startup from Buffalo, New York, USA. The goal is to improve the clinical outcomes of infections and wound healing. Garwood's products include Bio Prax, a minimally invasive device designed to prevent biofilm infections on prosthetic knee implants using electrodes to prevent microbial growth. Recently, the US Food and Drug Administration awarded it the title of an advanced device. The Series B round closed at the end of November 2019 at $3.7 million. The funds were added to the September 2016 Series A round, which raised $3.6 million.
A medical equipment startup provides neurostimulation products to radically improve the quality of life of patients with inflammatory diseases and chronic pain. The first product of the startup uses micro-pulses of electric current to heal the vagus nerve by means of an ear clamp electrode. The device will soon be available in the US outside of research laboratories. Users describe the Parasym device as life-changing.
A startup from Galway, Ireland. Develops innovative implantation technologies to promote postoperative wound healing and prevent infection in patients with colorectal cancer. Current treatment options for potential Signum Surgical patients have unsatisfactory outcomes, including slow healing, infections, and repeated surgeries. In the future, Signum Surgical hopes to expand its product range for the treatment of other colon diseases. In April 2016, Signum Surgical announced that it had raised 3.6 million euros (approximately $3.97 million) through two grant awards to bring the Bio Healx device to market. The funds will be used to support a 12-month clinical trial of Bio Healx.
A medical equipment startup from Boston, Massachusetts, USA, has created the first commercially available device for removing CO, which provides an economical, safe and widely available treatment option for patients with acute respiratory failure. A hybrid approach to treatment was created, in which the patient's blood is taken at a rate of <300 ml/min and flows through small catheters. The X-Cor product is not only less invasive than existing approaches to the treatment of acute pulmonary insufficiency, but also requires less training of personnel, and can also be used outside the intensive care unit. Alira Health Ventures announced that X-Cor joined its venture portfolio in November 2019.
A startup founded by a Brigham Young University student Eric Stopper. MedTech uses nanotechnology attached to an elastic band for pregnant women to monitor fetal activity during high-risk pregnancy, including monitoring the number of strokes, fetal heart rate and its position. The monitor can send alerts to the expectant mother's smartphone in case of a risk to help prevent stillbirth, premature birth or other negative pregnancy outcomes. Stopper won the first prize of the Utah Entrepreneur Challenge in 2017, which he planned to use to launch the Rubi Lifephone app. In 2018, the startup launched a Kickstarter to further develop the product in the hope of bringing "peace of mind" to expectant mothers around the world.
Day Zero Diagnostics
A startup from Boston, Massachusetts, USA. Uses machine learning to create rapid whole genome sequencing diagnostics to provide a deeper understanding of the profile and treatment options for life-threatening bacterial infections. MedTech's startup aims to create faster and more effective clinical support systems for the diagnosis and treatment of high-speed infections, such as sepsis, which can lead to the death of a patient within 2-5 hours. Day Zero Diagnostics completed an $8.6 million Series A round in April 2019. The startup hopes to use the funds to accelerate prototype development and implement sequencing-based diagnostics in a clinical setting.
Flatiron Health is a pioneer in developing oncology products in the cloud to create a common technology platform for oncologists, scientists, hospitals, researchers and regulators. OncoCloud is the most comprehensive set of software and cloud services for practicing oncologists who treat patients in the community. In addition, Flatiron works closely with regulators, scientists and hospitals to improve cancer treatment with accurate patient data.
Founded in 2008, Livongo is a pioneer in the use of signals for personalized care of patients with chronic diseases. The platform provides an opportunity to support diabetics, manage weight, hypertension, diabetes prevention and behavioral characteristics. Patients can be able to manage their health status using a smartphone app and connected devices, such as a connected blood glucose monitor or fitness tracker, while their progress is monitored by a medical trainer or clinician. Livongo was the first company to apply mHealth and data science techniques to disease management, including interactive prompts that advise patients to take actions that are most likely to have a clinical impact. After raising $237 million from investors, Livongo went public in July 2019. At the time of the IPO, Livongo had about 700 corporate clients.
The startup focuses on developing new ways to interact with the human brain using the latest technologies. The goal is to provide patients with neurological disorders or sensory deficits with new opportunities to adapt and improve their condition on their own, plus increasing the patient's adaptability while improving the quality of life, as well as developing a system of new indications for rehabilitation after stroke, neuroprosthetics and computer/brain interaction. Founded in 2019 in Munich, Germany, the company received an investment in start-up capital in January 2020.
The startup, founded in 2016 in France, is a virtual medical practice. It provides French residents in London with unlimited access, seven days a week, to an exclusive network of French medical specialists and specialists based in both France and the UK. His services are also available via video, if necessary, include home visits and meetings with French doctors. Covering more than 12 specialties, Qare is the first telemedicine platform offering innovative and holistic medical services to the Francophone community based in London. In April last year, the startup received an investment of 20 million euros.
The startup, founded in 2017 and based in Stockholm, is a patient-focused research platform for improving medicines, health and prevention. Elsa allows patients to become researchers of their own body, providing them with a better understanding of how lifestyle factors can affect the development of their disease in rheumatoid arthritis. To support patients from a scientific point of view, Elsa provides access to data on rheumatic diseases through the Riskminder Foundation and research at the Karolinska Institute. Thanks to the data, patients will be able to see, among other things, how adherence to medications and lifestyle factors affect the prognosis of their disease.
The startup, based in Rennes, France, is deploying a regulatory platform for medical transport, bringing together institutions, medical transport specialists and patients. Their goal is to provide an efficient and flexible experience by offering a transparent model to the players involved, solving the problem of patient flows for institutions, carriers and patients. Founded in 2018, in February 2020, the company raised an initial round of 1.1 million euros to become a benchmark for transport and logistics in the European healthcare industry.
Kheiron Medical Technologies
A startup for early detection of breast cancer. Uses advanced machine learning technologies to provide intelligent tools for radiologists. Combining new teaching methods, data science and radiological understanding, the startup helps doctors find malignant neoplasms on mammograms with modern detection support for breast cancer screening. Founded in 2016 and based in London, the company closed a Series A round in September 2019 in the amount of 20 million euros.
The startup is focused on the inclusion of micro-sensor technologies in invasive medical devices that provide communication with other medical machines, in order to identify biological tissues upon contact. He is a pioneer in the connected medical revolution with the world's smallest biological tissue sensor. The company, founded in 2014 and based in Massy, France, closed the series round in January 2020 In the amount of 9 million euros.
A startup from Muttenze, Switzerland, has developed a new approach to determining bacterial resistance to antibiotics, which significantly reduces the time to obtain results. The proposal is an alternative to the current gold standard in antibiotic sensitivity testing. The method reduces the time required for the test from several days to several hours, since it does not depend on the growth of bacteria. Founded in 2018, in December 2019, the company raised a Series A round of 3.6 million euros.
An award-winning Irish startup. A manufacturer of medical equipment specializing in the development of orthopedic technologies. The company has developed a new surgical implant for patients with arthritis in the joint of the base of the thumb, improving the quality of previous and existing solutions for patients. This is a condition that impairs the ability to perform simple tasks with the thumb, such as turning keys or controlling a mobile phone. The company's solution allows patients to regain mobility. Founded in 2017 and based in Galway, Ireland, the company recently received a grant from the European Commission in the amount of 2.8 million euros.
The startup was founded in Berlin in 2017, is a holistic European company using cannabis for medical purposes, focusing on health, well-being and scientific research. The company is unlocking the potential of cannabinoids to develop innovative cannabis-based pharmaceuticals and wellness products. She is fully licensed and currently works with two partners: Sanatio Pharma, a medical cannabis company engaged in the development of new treatments and pharmaceuticals, and the wellness brand VAAY. In February of this year, the startup raised $20.1 million in Series A funding.
The company has developed an innovative system for the colonoscopy procedure that guarantees safe, fast and easy advancement of the endoscope in the colon, providing a faster colonoscopy completion rate, less need for general anesthesia, less stress on the walls of the colon and lower costs. The magnetic armature that guides the device through the intestine makes it easier to perform complex colonoscopies. Founded in 2018 and based in Certaldo, Italy, the company closed an initial round of 1 million euros in December 2018.
Portal "Eternal youth" http://vechnayamolodost.ru